We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSACU
4826
DELISTED
Vision Sensing Acquisition Corp. Unit
VSACU
$4.02K ﹤0.01%
359
XTIA icon
4827
XTI Aerospace
XTIA
$58.9M
$4.02K ﹤0.01%
36
+31
+620% +$13.4K
SIF icon
4828
SIFCO Industries
SIF
$176M
$4.02K ﹤0.01%
1,297
-39
-3% -$124
HCWB icon
4829
HCW Biologics
HCWB
$5.45M
$4.02K ﹤0.01%
26
+5
+24% +$1.48K
RHE
4830
DELISTED
Regional Health Properties, Inc.
RHE
$4.01K ﹤0.01%
1,939
+981
+102% +$2.58K
FMS icon
4831
Fresenius Medical Care
FMS
$12.9B
$4.01K ﹤0.01%
210
-8,199
-98% -$167K
BSET icon
4832
Bassett Furniture
BSET
$176M
$4.01K ﹤0.01%
282
-513
-65% -$7.21K
EEMV icon
4833
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$4K ﹤0.01%
70
-17
-20% -$964
TTNP
4834
DELISTED
Titan Pharmaceuticals
TTNP
$3.99K ﹤0.01%
717
+70
+11% +$475
BSBR icon
4835
Santander
BSBR
$43.5B
$3.99K ﹤0.01%
808
-9,924
-92% -$53.1K
XLO icon
4836
Xilio Therapeutics
XLO
$60.3M
$3.99K ﹤0.01%
301
-496
-62% -$7.76K
BOF icon
4837
BranchOut Food
BOF
$63.6M
$3.99K ﹤0.01%
5,728
+4,887
+581% +$7.87K
PHIO icon
4838
Phio Pharmaceuticals
PHIO
$12.1M
$3.97K ﹤0.01%
637
+4
+0.6% +$26
BOXL icon
4839
Boxlight
BOXL
$2.13M
$3.96K ﹤0.01%
36
EVOK
4840
DELISTED
Evoke Pharma
EVOK
$3.96K ﹤0.01%
623
+6
+1% +$36
EPOL icon
4841
iShares MSCI Poland ETF
EPOL
$818M
$3.92K ﹤0.01%
160
+155
+3,100% +$3.76K
IEFA icon
4842
iShares Core MSCI EAFE ETF
IEFA
$196B
$3.92K ﹤0.01%
54
-6,979
-99% -$514K
BYRN icon
4843
Byrna Technologies
BYRN
$101M
$3.92K ﹤0.01%
393
-1,380
-78% -$17K
HYEM icon
4844
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
$3.9K ﹤0.01%
204
+4
+2% +$76
FMED icon
4845
Fidelity Disruptive Medicine ETF
FMED
$47.8M
$3.9K ﹤0.01%
162
CONY icon
4846
YieldMax COIN Option Income Strategy ETF
CONY
$336M
$3.89K ﹤0.01%
19
-114
-86% -$26.5K
AZUL
4847
DELISTED
Azul
AZUL
$3.89K ﹤0.01%
+973
New +$5.7K
CAUD
4848
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
$3.86K ﹤0.01%
+7,139
New +$3.52K
ALIM
4849
DELISTED
Alimera Sciences
ALIM
$3.86K ﹤0.01%
694
-250
-26% -$888
REBN icon
4850
Reborn Coffee
REBN
$12.4M
$3.85K ﹤0.01%
553
-7,163
-93% -$23.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.